UCLB Investor Breakfasts 2008
February Breakfast: BioMedicine
Date: February 26th
Venue: The Haldane Room, UCL,
A Great Success!
Many thanks to all who attended. By all accounts the event was a great success, and judging by the feedback, we're delighted you found it a useful event:
- "I found the event to be very interesting," Robert Brooke of Fordhouse
- "The event was put together really well,'" Dr. Pavithra Sundaresan, Atlas Venture
For those who were unable to attend, we're sorry not to have seen you, but please click on the links below to download the presentations that you missed.
- A novel treatment for hepatic encephalopathy
- Small molecule carriers – importing cargo into cells
- ProAxon: Neural protective sodium channel antagonists – a novel treatment for multiple sclerosis
- Canbex - A new drug for treatment of spasticity in MS
- Evexar – Medical devices designed by surgeons for surgeons
- Endomagnetics - SentiMAG™, for the staging and treatment of breast cancer
- DDAH small molecule antagonists for the treatment of sepsis
- DARC and novel imaging techniques in glaucoma
- Drug lifecycle Visualisation Tool - In Vivo
- The London Project to Cure Blindness: stemming vision loss using stem cells
If you have any queries on projects or companies presented, please do not hesitate to get in touch. We hope to see you at our next Investor Breakfast at 8am on April 29th where we will feature cancer and stem cell opportunities at UCL.
